BR112022015507A2 - Processos para produzir compostos de amida, e sua forma cristalina e salina - Google Patents

Processos para produzir compostos de amida, e sua forma cristalina e salina

Info

Publication number
BR112022015507A2
BR112022015507A2 BR112022015507A BR112022015507A BR112022015507A2 BR 112022015507 A2 BR112022015507 A2 BR 112022015507A2 BR 112022015507 A BR112022015507 A BR 112022015507A BR 112022015507 A BR112022015507 A BR 112022015507A BR 112022015507 A2 BR112022015507 A2 BR 112022015507A2
Authority
BR
Brazil
Prior art keywords
amide compounds
crystalline
processes
producing amide
saline form
Prior art date
Application number
BR112022015507A
Other languages
English (en)
Inventor
Chung Cheng-Ho
Tseng Shi-Liang
Hsu Hsiang-En
Original Assignee
Alphala Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alphala Co Ltd filed Critical Alphala Co Ltd
Publication of BR112022015507A2 publication Critical patent/BR112022015507A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/10—1,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles
    • C07D271/107—1,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles with two aryl or substituted aryl radicals attached in positions 2 and 5
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C313/00—Sulfinic acids; Sulfenic acids; Halides, esters or anhydrides thereof; Amides of sulfinic or sulfenic acids, i.e. compounds having singly-bound oxygen atoms of sulfinic or sulfenic groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C313/02—Sulfinic acids; Derivatives thereof
    • C07C313/06—Sulfinamides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

PROCESSOS PARA PRODUZIR COMPOSTOS DE AMIDA, E SUA FORMA CRISTALINA E SALINA. São divulgados processos para produzir compostos de amida, e sua forma cristalina e salina. Neste documento, um dos compostos de amida é representado pela seguinte Fórmula (1): que é caracterizado por um padrão de difração de raios x (XRD) tendo picos em cerca de 14,2, 15,6, 16,4, 20,1, 20,5 e 21,2° ± 0,2° 2Teta.
BR112022015507A 2020-03-06 2021-03-03 Processos para produzir compostos de amida, e sua forma cristalina e salina BR112022015507A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202062985918P 2020-03-06 2020-03-06
PCT/US2021/020595 WO2021178486A1 (en) 2020-03-06 2021-03-03 Processes for producing amide compounds, and their crystalline and salt form

Publications (1)

Publication Number Publication Date
BR112022015507A2 true BR112022015507A2 (pt) 2022-09-27

Family

ID=77613709

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112022015507A BR112022015507A2 (pt) 2020-03-06 2021-03-03 Processos para produzir compostos de amida, e sua forma cristalina e salina

Country Status (12)

Country Link
US (1) US20230131180A1 (pt)
EP (1) EP4114823A4 (pt)
JP (1) JP2023516082A (pt)
KR (1) KR20220137084A (pt)
CN (1) CN115052855A (pt)
AU (2) AU2021231787B2 (pt)
BR (1) BR112022015507A2 (pt)
CA (1) CA3170348A1 (pt)
IL (1) IL296041A (pt)
MX (1) MX2022011025A (pt)
TW (1) TWI787751B (pt)
WO (1) WO2021178486A1 (pt)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2013006768A (es) * 2010-12-23 2013-07-22 Pfizer Moduladores de receptor de glucagon.
EA023517B1 (ru) * 2011-02-08 2016-06-30 Пфайзер Инк. Модуляторы глюкагонового рецептора
US10882837B2 (en) * 2017-01-24 2021-01-05 Alphala Co., Ltd. Amide compounds and use thereof
EP3640242B1 (en) * 2017-06-16 2023-04-19 Hitgen Ltd. Rock-inhibiting compound and uses thereof

Also Published As

Publication number Publication date
AU2021231787A1 (en) 2022-08-25
WO2021178486A1 (en) 2021-09-10
EP4114823A4 (en) 2024-06-19
MX2022011025A (es) 2022-10-07
AU2021231787B2 (en) 2023-08-17
US20230131180A1 (en) 2023-04-27
CA3170348A1 (en) 2021-09-10
CN115052855A (zh) 2022-09-13
JP2023516082A (ja) 2023-04-17
TW202142534A (zh) 2021-11-16
EP4114823A1 (en) 2023-01-11
AU2023266374A1 (en) 2023-12-07
IL296041A (en) 2022-10-01
TWI787751B (zh) 2022-12-21
KR20220137084A (ko) 2022-10-11

Similar Documents

Publication Publication Date Title
MX2020009957A (es) Compuestos para el tratamiento de enfermedad de hungtinton.
CY1124257T1 (el) N-[4-ΦΘOPO-5-[[(2S,4S)-2-MEΘYΛO-4-[(5-MEΘYΛO-1,2,4-ΟΞAΔIAZOΛ-3-YΛO)MEΘOΞY]-l-ΠΙΠΕΡΙΔΥΛΟ]ΜΕΘΥΛΟ]ΘΕΙΑΖΟΛ-2-ΥΛΟ]ΑΚΕΤΑΜΙΔΙΟ ΩΣ ΑΝΑΣΤΟΛΕΑΣ OGA
Page et al. Identification of a non-phosphorylated, cell permeable, small molecule ligand for the Stat3 SH2 domain
PH12020551488A1 (en) Novel calcium salt polymorphs as anti-inflammatory, immunomodulatory and anti-proliferatory agents
BR0109851A (pt) Composto, método para produzir o mesmo ou um sal deste, pró medicamento, composição farmacêutica, método para inibir a tirosina cinase, método para prevenir ou tratar câncer, e, uso de um composto ou de um sal ou pró medicamento deste
BR112017007744A2 (pt) cartucho de grampos compreendendo um material adjunto
BR112019005929A2 (pt) métodos para preparar um catalisador
BR112017016837A2 (pt) modificação cristalina de um composto material de gravação, e, lâmina de gravação.
EA200601271A1 (ru) Новая кристаллическая форма iv агомелатина, способ её получения и фармацевтические композиции, которые её содержат
BR112017010621A2 (pt) produtos à base de sulfato de cálcio resistentes a fogo
CY1124387T1 (el) Μεθοδος για παραγωγη νεας χημικης ενωσης που περιεχει αζωτο ή αλατος αυτης, και παραγωγη ενδιαμεσου της ιδιας
BR112022012546A2 (pt) Método para produzir conjugado anticorpo-fármaco à base de eribulina
BR112022000713A2 (pt) Imidazopirimidinas como inibidores de eed e o uso das mesmas
BR112015019437A2 (pt) complexo de bis(2-indenil) metaloceno
GEP20247655B (en) Crystalline salt forms of kinase inhibitor
BR112022015109A2 (pt) Compostos e usos dos mesmos
BR112022015507A2 (pt) Processos para produzir compostos de amida, e sua forma cristalina e salina
BR112017026582A2 (pt) método para formar um revestimento de um dispositivo eletrônico ou elétrico
ES2169242T3 (es) 2-amino-benzoxazinonas para el tratamiento de infecciones virales.
BR0211276A (pt) Processo para propagação de vìrus
BR112021024399A2 (pt) Método para produzir um aglutinante, aglutinante, uso de um aglutinante, e, produto químico para construção
CL2023000412A1 (es) Derivados cíclicos de quemerina–9
EA202191158A1 (ru) Новый способ получения n,n'-бис[2-(1н-имидазол-4-ил)этил]малонамида
ES506337A0 (es) Procedimiento para la preparacion de derivados de guanidina
BR112018004459A2 (pt) método para a (co)polimerização do radical e (co)polímero acrílico associativo